Acne Treatment Research 2026: From Clinical Trials to Your Skin

Spironolactone studies, microbiome-based therapies, and light treatments are advancing acne care. Here is what the latest research reveals.

Get research like this in your inbox — free

Spironolactone: Stronger Evidence for Hormonal Acne

Spironolactone has been prescribed off-label for hormonal acne for years, but 2026 is bringing the kind of rigorous evidence that the dermatology community has been waiting for. A landmark randomized, double-blind, placebo-controlled trial published this year enrolled over 400 women with moderate-to-severe hormonal acne and definitively showed that spironolactone at 100mg daily significantly reduced acne lesion counts and improved quality-of-life scores compared to placebo.

The study also provided important safety data, confirming that serious adverse events were rare in the study population (women of reproductive age using contraception). Common side effects included increased urination and mild dizziness, consistent with the drug's mechanism as a potassium-sparing diuretic. Potassium monitoring was required but clinically significant hyperkalemia was uncommon.

Additional 2026 studies are examining lower doses and combination approaches. Research suggests that spironolactone combined with a topical retinoid may be particularly effective, allowing lower doses of both medications with fewer side effects.

What this means for you: If you are a woman dealing with hormonal acne, particularly along the jawline and chin, research now more strongly supports spironolactone as an effective treatment. It is not appropriate for everyone, so discuss with your dermatologist whether it could be right for your acne pattern.

The Skin Microbiome: A New Treatment Frontier

One of the most fascinating areas of acne research in 2026 involves the skin microbiome. Rather than killing all bacteria (the traditional approach with antibiotics), researchers are studying whether rebalancing the microbial community on the skin can treat acne more sustainably.

A 2026 clinical trial tested a topical probiotic formulation containing a strain of Cutibacterium acnes (C. acnes) that does not cause acne. The idea is that these "good" strains compete with acne-causing strains for resources. The results showed modest but significant reductions in inflammatory lesions, with an excellent safety profile.

Other research groups are studying bacteriophages, viruses that specifically target acne-causing bacteria without affecting beneficial skin microbes. A Phase 1/2 trial published in 2026 demonstrated that a topical bacteriophage cocktail reduced C. acnes populations and improved acne scores with minimal side effects.

Researchers are also finding that the gut microbiome may influence acne through the gut-skin axis. A 2026 study found correlations between gut microbial diversity and acne severity, though whether oral probiotics can improve acne remains an active area of investigation.

What this means for you: Microbiome-based acne treatments are still emerging, but the research direction is promising. For now, it is worth being cautious about over-cleansing or excessive antibiotic use that could disrupt your skin microbiome. Talk to your dermatologist about microbiome-friendly approaches to acne care.

Light and Laser Therapy: Updated Evidence

Light-based treatments for acne continue to be studied in 2026. Blue light therapy, which targets the porphyrins produced by acne bacteria, has been available for years, but newer studies are combining it with red light (which has anti-inflammatory properties) in optimized protocols.

A 2026 randomized trial found that a specific combination protocol of blue and red LED therapy, used at home for 20 minutes daily over 12 weeks, reduced inflammatory acne lesions by approximately 50% compared to sham treatment. While not as effective as prescription medications for severe acne, this offers a drug-free option for mild-to-moderate cases.

Researchers are also studying photodynamic therapy (PDT) with shorter incubation times, which may reduce the severe post-treatment redness and peeling that limited earlier PDT protocols. Studies in 2026 show that these modified protocols maintain efficacy while being better tolerated.

What this means for you: Light therapy can be a useful tool for mild-to-moderate acne, particularly if you prefer non-medication approaches. Home devices are becoming more evidence-based. Discuss with your dermatologist whether light therapy could complement your acne treatment plan.

Retinoids: Still the Backbone, Getting Refined

Retinoids remain a cornerstone of acne treatment, and 2026 research focuses on making them more tolerable. Studies on newer retinoid formulations, including trifarotene and microencapsulated tretinoin, show comparable efficacy to traditional formulations with significantly less irritation, which may improve adherence.

Want to stay updated on acne research? Sign up for free alerts and get plain-English summaries delivered to your inbox.

This article summarizes published research and is not medical advice. Discuss any findings with your healthcare provider before making decisions about your care. Content is generated with AI assistance and reviewed for accuracy.

Related Conditions on Rivvet

Stay on top of the research that matters to you